Polymorphous Low Grade Adenocarcinoma Has a Consistent P63+/p40- Immunophenotype That Helps Distinguish It from Adenoid Cystic Carcinoma and Cellular Pleomorphic Adenoma

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2014 Jun 28

PMID 24969705

Citations 35

Authors

Lisa Rooper

Rajni Sharma

Justin A Bishop

Affiliations

Soon will be listed here.

Abstract

Polymorphous low grade adenocarcinoma (PLGA) is a tumor of minor salivary glands that exhibits considerable morphologic overlap with adenoid cystic carcinoma and cellular pleomorphic adenoma, especially in small biopsy specimens. Unlike these other tumor types. PLGAs do not harbor a myoepithelial component, yet their frequent positivity for p63 diminishes the usefulness of this particular myoepithelial marker as a discriminating immunostain. p40 is an antibody that recognizes ΔNp63, a p63 isoform that is more specific for true myoepithelial differentiation. As such, p40 immunostaining could help distinguish PLGAs from adenoid cystic carcinomas and pleomorphic adenomas. In this study, p63 and p40 immunohistochemistry was performed on paraffin embedded, formalin fixed tissue from 11 PLGAs, 101 adenoid cystic carcinomas, and 31 pleomorphic adenomas. All 11 PLGAs (100 %) were positive for p63 but completely negative for p40. Among adenoid cystic carcinomas, 91 of 101 (90 %) were positive for p63 and 90/101 (89 %) were positive for p40. The single discordant p63+/p40- adenoid cystic carcinoma exhibited solid architecture and high grade features not typically seen in PLGA. Among pleomorphic adenomas, 21/31 (68 %) were positive for p63 and 13/31 (42 %) were positive for p40. For the pleomorphic adenomas, the discordant p63+/p40- staining pattern was seen only in the overtly mesenchymal chondromyxoid stroma. The cellular epithelial component of the pleomorphic adenomas demonstrated concordant p63+/p40+ or p63-/p40- immunophenotypes. PLGA consistently exhibits a p63+/p40- immunophenotype that can help distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma, tumors that characteristically demonstrate concordant p63 and p40 immunostaining patterns. A p63/p40 immunohistochemical panel can provide a valuable tool for making the distinction between these morphologically similar but clinically divergent entities.

Citing Articles

Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers.

Broseghini E, Carosi F, Berti M, Compagno S, Ghelardini A, Fermi M Cancers (Basel). 2025; 17(4).

PMID: 40002255 PMC: 11852825. DOI: 10.3390/cancers17040660.

Atypical and worrisome histological features in pleomorphic adenoma: challenging and potentially significant diagnostic pitfall.

de Lima-Souza R, Belohlavkova K, Michal M, Altemani A, Mariano F, Skalova A Virchows Arch. 2025; .

PMID: 39827206 DOI: 10.1007/s00428-024-04015-z.

A rare case of an aggressive polymorphous adenocarcinoma of minor salivary gland in the retro-maxilla.

Saha M, Kudva A, Sharma S, Singh R J Oral Maxillofac Pathol. 2024; 28(3):478-482.

PMID: 39670142 PMC: 11633936. DOI: 10.4103/jomfp.jomfp_13_24.

Microsecretory adenocarcinoma of the hard palate: a case report and literature review.

Lu Y, Wen Y, Feng S, Huang W Diagn Pathol. 2024; 19(1):95.

PMID: 38982505 PMC: 11232280. DOI: 10.1186/s13000-024-01514-0.

Clinicopathological Features of 26 Intraoral Polymorphous Adenocarcinomas from a Single Brazilian Institution.

de Aquino S, de Caceres C, Bezerra H, de Paiva J, Louredo B, Santos-Silva A Head Neck Pathol. 2024; 18(1):63.

PMID: 38958847 PMC: 11222357. DOI: 10.1007/s12105-024-01666-x.

References

Edwards P, Bhuiya T, Kelsch R . Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97(5):613-9. DOI: 10.1016/S1079210403005742. View

Beltran D, Faquin W, Gallagher G, August M . Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg. 2006; 64(3):415-23. DOI: 10.1016/j.joms.2005.11.027. View

Curran A, White D, Damm D, Murrah V . Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91(2):194-9. DOI: 10.1067/moe.2001.111306. View

Park C, Oh Y . Expression of p63 in reactive hyperplasias and malignant lymphomas. J Korean Med Sci. 2005; 20(5):752-8. PMC: 2779270. DOI: 10.3346/jkms.2005.20.5.752. View

Epivatianos A, Iordanides S, Zaraboukas T, Antoniades D . Adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of minor salivary glands: a comparative immunohistochemical study using the epithelial membrane and carcinoembryonic antibodies. Oral Dis. 2005; 11(3):175-80. DOI: 10.1111/j.1601-0825.2005.01110.x. View

Prasad A, Savera A, Gown A, Zarbo R . The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999; 123(9):801-6. DOI: 10.5858/1999-123-0801-TMIIBA. View

Kakarala K, Bhattacharyya N . Survival in oral cavity minor salivary gland carcinoma. Otolaryngol Head Neck Surg. 2010; 143(1):122-6. DOI: 10.1016/j.otohns.2010.02.033. View

Aberle A, Abrams A, Bowe R, Melrose R, Handlers J . Lobular (polymorphous low-grade) carcinoma of minor salivary glands. A clinicopathologic study of twenty cases. Oral Surg Oral Med Oral Pathol. 1985; 60(4):387-95. DOI: 10.1016/0030-4220(85)90261-0. View

Lazzaro B, Cleveland D . P53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89(5):613-7. DOI: 10.1067/moe.2000.105765. View

10.

Crum C, McKeon F . p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol. 2010; 5:349-71. DOI: 10.1146/annurev-pathol-121808-102117. View

11.

Lee S, Kim B, Choi E . Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma. Head Neck. 2013; 36(12):1796-801. DOI: 10.1002/hed.23537. View

12.

Tilson M, Bishop J . Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract. Head Neck Pathol. 2013; 8(2):141-5. PMC: 4022944. DOI: 10.1007/s12105-013-0496-2. View

13.

Araujo V, Loducca S, Sousa S, Williams D, Araujo N . The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression. Ann Diagn Pathol. 2001; 5(6):330-4. DOI: 10.1053/adpa.2001.29339. View

14.

Bishop J, Montgomery E, Westra W . Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014; 38(2):257-64. PMC: 4313886. DOI: 10.1097/PAS.0000000000000119. View

15.

Venkata V, Irulandy P . The frequency and distribution pattern of minor salivary gland tumors in a government dental teaching hospital, Chennai, India. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 111(1):e32-9. DOI: 10.1016/j.tripleo.2010.08.019. View

16.

Frierson Jr H, Mills S, Garland T . Terminal duct carcinoma of minor salivary glands. A nonpapillary subtype of polymorphous low-grade adenocarcinoma. Am J Clin Pathol. 1985; 84(1):8-14. DOI: 10.1093/ajcp/84.1.8. View

17.

Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T . Clinico-pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci. 2006; 97(10):1050-5. PMC: 11159472. DOI: 10.1111/j.1349-7006.2006.00284.x. View

18.

Penner C, Folpe A, Budnick S . C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002; 15(7):687-91. DOI: 10.1097/01.MP.0000018973.17736.F8. View

19.

Pires F, Pringle G, de Almeida O, Chen S . Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol. 2006; 43(5):463-70. DOI: 10.1016/j.oraloncology.2006.04.008. View

20.

Loducca S, Raitz R, Araujo N, Araujo V . Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: distinct architectural composition revealed by collagen IV, laminin and their integrin ligands (alpha2beta1 and alpha3beta1). Histopathology. 2000; 37(2):118-23. DOI: 10.1046/j.1365-2559.2000.00900.x. View